However, we found that only p53 wild-type tumor cell lines are able to suppress 4E-BP1 phosphorylation in the presence of DNA damage, indicating that p53 protein is required for the inhibition of 4E-BP1 but not rpS6. Here, RPS6 is linked to neoplasm.